A Short Synthetic Route to 4,7‐Dihalogenated 1,10‐Phenanthrolines with Additional Groups in 3,8‐Position: Soluble Precursors for Macrocyclic Oligophenanthrolines
H2-Antihistaminika, 18. Mitt. 5,6-Alkylsubstituierte 4-Pyrimidinone mit H2-antihistaminischer Wirkung
作者:Jan-Peter Spengler、Walter Schunack
DOI:10.1002/ardp.19843170509
日期:——
5,6‐Alkylsubstituierte 2‐2‐[(5‐Methyl‐4‐imidazolyl)‐methylthio]‐ethylamino}‐4‐pyrimidinone wurden dargestellt und auf ihre H2‐antihistaminische Wirksamkeit untersucht.
[EN] PYRIMIDINONE COMPOUNDS FOR USE IN THE TREATMENT OF DISEASES OR CONDITIONS MEDIATED BY LP - PLA2<br/>[FR] COMPOSÉS DE PYRIMIDINONE UTILES DANS LE TRAITEMENT DE MALADIES OU D'ÉTATS PATHOLOGIQUES INDUITS PAR LA LP-PLA2
申请人:GLAXO GROUP LTD
公开号:WO2012076435A1
公开(公告)日:2012-06-14
The present invention relates to novel compounds that inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema (I).
A Short Synthetic Route to Novel, Highly Soluble 3,8-Dialkyl-4,7-dibromo-1,10-phenanthrolines
作者:Michael Schmittel、Horst Ammon
DOI:10.1055/s-1997-1525
日期:1997.9
A short and convenient synthesis of highly soluble 3,8-dialkyl-4,7-dibromo-1,10-phenanthrolines is described. These compounds are versatile key building blocks for the preparation of macrocyclic oligophenanthrolines with exo-coordination sites.
The present invention relates to novel compounds that inhibit Lp-PLA
2
activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA
2
, for example atherosclerosis, Alzheimer's disease, and/or diabetic macular edema.